Very Brief Blog: Jury Awards CareDx $45M in Advertising-Based Lawsuit

In an unusual case, a jury awarded CareDx $44.9M in a false advertising lawsuit against Natera.

But according to an article on Genomeweb, "the jury also found CareDx liable for two instances of false advertising."

See the full article at Genomeweb:

https://www.genomeweb.com/sequencing/jury-awards-caredx-449m-natera-lawsuit-finds-both-companies-engaged-false-advertising

See also coverage at Reuters:

https://www.reuters.com/legal/litigation/caredx-wins-45-mln-verdict-against-natera-false-advertising-2022-03-15/

CareDx and Natera have also haggled over patents (November 2021):

https://www.jdsupra.com/legalnews/caredx-v-natera-extrinsic-evidence-5443760/